Technology / Scientific & Technical InstrumentsNasdaqGS
$105.26
+3.24 (+3.18%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $41.6M · quality 70.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$582M
P/E
87.0x
↑EV/EBITDA
17.1x
↑ROE
-1.2%
↓Gross Margin
62.6%
↑Debt/Equity
1.14
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2011–2025 · 14 años de histórico normalizado
Revenue CAGR
+15.0%
FCF CAGR
—
FCF margin
17.6%
FCF / Net income
-21.43x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $241.0M · net income $-2.0M · FCF $42.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | $241.0M | $241.0M | $216.2M | $219.1M | $184.3M | $133.9M | $117.7M | $103.1M | $96.2M | $93.7M | $84.7M | $71.3M | $52.7M | $46.4M | $39.6M | $34.2M |
| Net Income | $-2.0M | $-2.0M | $-254.2M | $930000.00 | $1.9M | $3.3M | $1.8M | $7.5M | $-3.0M | $11.2M | $11.2M | $9.6M | $9.0M | $8.4M | $7.9M | $6.2M |
| EBITDA | $42.3M | $42.3M | $-238.4M | $37.5M | $32.5M | $30.0M | $20.9M | $19.2M | $11.7M | $25.1M | $23.5M | $21.5M | $15.6M | $16.5M | $14.7M | $11.7M |
| EPS | -0.36 | -0.36 | -47.20 | 0.17 | 0.35 | 0.64 | 0.41 | 1.86 | -0.79 | 2.91 | 2.97 | 2.63 | 2.49 | 2.35 | 2.29 | 1.86 |
| Gross Margin | 62.6% | 62.6% | 61.6% | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% | 60.7% | 60.8% | 60.1% | 62.2% | 59.3% | 57.2% |
| Operating Margin | 6.8% | 6.8% | 1.1% | 1.5% | 2.6% | 9.2% | 6.7% | 9.5% | 2.3% | 17.4% | 19.3% | 22.2% | 22.4% | 28.2% | 31.5% | 28.8% |
| Net Margin | -0.8% | -0.8% | -117.6% | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% | -3.1% | 11.9% | 13.2% | 13.4% | 17.1% | 18.2% | 20.0% | 18.1% |
| Balance Sheet | ||||||||||||||||
| Debt/Equity | 1.14 | 1.14 | 1.55 | 0.47 | 0.56 | — | — | 0.19 | 0.45 | 0.55 | 0.50 | 0.32 | 0.26 | 0.08 | — | 0.04 |
| Cash Flow | ||||||||||||||||
| Free Cash Flow | $42.3M | $42.3M | $41.6M | $23.4M | $34.8M | $35.1M | $25.5M | $29.3M | $22.9M | — | — | — | — | — | — | — |
| Returns | ||||||||||||||||
| ROE | -1.2% | -1.2% | -174.9% | 0.2% | 0.5% | 0.8% | 0.8% | 6.7% | -3.0% | 11.4% | 13.2% | 13.0% | 14.0% | 16.0% | 18.0% | 17.0% |
| Valuation | ||||||||||||||||
| P/E | 86.99 | 86.99 | — | 1032.35 | 716.63 | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 17.11 | 17.11 | — | 29.16 | 46.42 | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 3.57 | 3.57 | 3.74 | 2.39 | 3.40 | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||
| Revenue Growth | 11.5% | 11.5% | -1.3% | 18.8% | — | 13.8% | 14.1% | 7.2% | 2.7% | 10.6% | 18.7% | 35.3% | 13.5% | 17.2% | 15.7% | — |
| EPS Growth | 99.2% | 99.2% | -27864.7% | -51.4% | — | 56.1% | -78.0% | 335.4% | -127.1% | -2.0% | 12.9% | 5.6% | 6.0% | 2.6% | 23.1% | — |
| Dividend Yield | 0.6% | 0.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+5.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-47.20 → -0.36
Residual
+4.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.